Dougherty & Co Upgrades IPC The Hospitalist Company (IPCM) to Buy
Tweet
Share
E-mailGet Alerts IPCM Hot Sheet
Price: $80.17 --0%
Rating Summary:
0 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Dougherty & Co.'s Brooks O'Neil and Deepak Chaulagai upgraded shares of IPC The Hospitalist Company (NASDAQ: IPCM) from Neutral to Buy following Tuesday afternoon's Q4 results and FY12 guidance. The firm's price target was raised from $41 to $45.
The analysts said, "In our mind, the key point is it looks like the worst is behind IPCM."
With IPC shares up 7 percent to $37.45 at last check, Dougherty's new price target represents potential upside of about 20 percent.
For an analyst ratings summary and ratings history on IPC The Hospitalist Company click here. For more ratings news on IPC The Hospitalist Company click here.
The analysts said, "In our mind, the key point is it looks like the worst is behind IPCM."
With IPC shares up 7 percent to $37.45 at last check, Dougherty's new price target represents potential upside of about 20 percent.
For an analyst ratings summary and ratings history on IPC The Hospitalist Company click here. For more ratings news on IPC The Hospitalist Company click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
Create E-mail Alert Related Categories
UpgradesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
